Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Iran J Child Neurol ; 17(3): 143-155, 2023.
Article in English | MEDLINE | ID: mdl-37637782

ABSTRACT

Objectives: Given that deficiency in B vitamins can lead to the accumulation of homocysteine (Hcy), and hyperhomocysteinemia may have a role in migraine pathogenesis, the present prospective randomized double-blinded placebo-controlled trial aimed to evaluate the effect of vitamin B-complex supplementation on the alleviation of migraine in children through a possible reduction in Hcy levels. Materials & Methods: Ninety children under 15 years of age suffering from typical migraine were included in the present trial. They were randomly assigned into two groups (forty-five patients in each group) to receive either vitamin B-complex or a matching placebo for six months. Serum Hcy levels and headache characteristics were evaluated and compared before and after administering vitamin B-complex or placebo. Results: Unlike the placebo group, the monthly headache frequency, severity of headache, headache disability, and serum Hcy levels were significantly decreased after the vitamin administration. The headache duration was not significantly different before and after the treatment. In the vitamin group, there were significant positive correlations between the frequency and severity, frequency and disability, and severity and disability of headaches. Hcy also had significant positive correlations with the frequency and disability of headaches. In the placebo group, the only found significant correlation was between headache frequency and disability. Conclusion: The administration of vitamin B-complex might effectively relieve migraine severity in children by reducing serum Hcy. However, further studies are needed to confirm the results.

2.
Curr Mol Med ; 21(2): 87-95, 2021.
Article in English | MEDLINE | ID: mdl-32520687

ABSTRACT

Exosomes are nano-sized vesicles secreted by nearly all cells and have received massive attention recently. In addition to their roles in pathophysiological processes and diagnostic evaluations, recently, several studies have applied exosomes to design novel therapeutic applications. Exosomes can be derived from a variety of cells and tissues and based on the source, they can carry different native contents such as DNAs, non-coding small RNAs, mRNAs, and proteins. They can also be engineered by adding desirable agents including specific biomolecules or drugs. Both forms can be therapeutically used for delivering their cargoes to the target cells and desirably alter their functions. The present study aimed to provide a comprehensive review of the various studies which applied exosomes as a therapeutic tool in the treatment of different types of diseases including cancer, cardiovascular, neurologic, psychiatric, liver, and kidney diseases.


Subject(s)
Biomarkers/metabolism , Brain Diseases/therapy , Cardiovascular Diseases/therapy , Exosomes/metabolism , Neoplasms/therapy , Protective Factors , Animals , Brain Diseases/metabolism , Brain Diseases/pathology , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/pathology , Drug Delivery Systems , Humans , Neoplasms/metabolism , Neoplasms/pathology
3.
Nutr Neurosci ; 24(4): 307-316, 2021 Apr.
Article in English | MEDLINE | ID: mdl-31241011

ABSTRACT

The ketogenic diet (KD) has been used for a long time as a therapeutic approach for drug-resistant epilepsy. It is a high-fat, low-carbohydrate, and adequate protein diet. There are various types of KD with some differences in their compositions that mainly include classic KD, medium-chain triglyceride diet, modified Atkins diet, and low glycemic index treatment. The anti-seizure mechanisms of KDs have not yet completely understood but, some possible mechanisms can be theorized. The aim of the present study was to review the various types of KD and explain the probable biochemical mechanisms involved in its anti-seizure property.


Subject(s)
Diet, Ketogenic , Drug Resistant Epilepsy , Seizures , Diet, Fat-Restricted , Diet, High-Protein Low-Carbohydrate , Drug Resistant Epilepsy/drug therapy , Glycemic Index , Humans , Seizures/drug therapy , Seizures/prevention & control , Treatment Outcome , Triglycerides
SELECTION OF CITATIONS
SEARCH DETAIL
...